Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01778803
Recruitment Status : Completed
First Posted : January 29, 2013
Last Update Posted : May 17, 2017
Information provided by (Responsible Party):
Verastem, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 23, 2015
  Study Completion Date : February 23, 2015